- Hiring, pay and restructuring: 4 HR leaders on difficult workforce decisions
- First free dental clinic opens in New Jersey
- The week in hospital M&A
- 5 dental insurance changes dentists need to know from the past 15 days
- A new medical school is opening nearby. What do health systems do first?
- ‘Snowbirds’ and ‘med-à-terres’: The market behaviors shaping systems’ growth decisions
- Indiana dental office manager sentenced to 36 months in prison for Medicaid fraud
- OpenAI says new ChatGPT model tops physician-written health answers
- CMS’ accreditation overhaul: What it means for hospitals
- Eli Lilly begins denying 340B discounts
- 5 cardiology leaders building the ASC ownership model
- What it actually takes to launch cardiac ablations in an ASC
- 5 federal, state legislative updates affecting the dental workforce
- Ebola cases jump 38% in 1 week: 5 things to know
- 34 recent hospital, health system executive moves
- Hospitals and health systems moving to new EHR platforms
- How many dentists the largest DSOs support
- 8 new behavioral health projects to know
- Anesthesia has a usage problem not a workforce shortage, leaders say
- Remain or Reimagine: Free Interactive Tool Shows Dentists the value of remaining independent vs partnering with Elevate
- Pennsylvania dental group settles patient coverage lawsuit for $1M
- Pennsylvania physicians push back on consolidation with first-ever independent practice summit
- The ASC procedure list is growing — here’s what’s still missing
- wRVU pay, hospital subsidies don’t constitute Stark law fraud, court rules
- Specialty dentists’ compensation has climbed 39% since 2019
- ASCs’ block time hoarding problem
- Oregon prosecutors urge state to fix mental health system
- Arkansas lab pays $30M to settle kickback allegations tied to gastroenterology practices
- The case for layering behavioral healthcare models
- Why dentistry needs a revamp
- Rural, independent Kansas hospitals launch clinically integrated network
- Nova Southeastern launches 1st anesthesiologist assistant program in Nevada
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- Cardiologists push back on CMS’ proposed pay policy changes
- 14,700 bottles of antidepressant recalled over impurity concerns
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- 7 DSOs making headlines
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- How Northwell is using paramedics to close behavioral healthcare gaps
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Readers Curse Medical Debt and Defend Spelling Therapy
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- 20 new behavioral health study findings to know
- 31 behavioral health executive moves to know
- Centerstone names COO
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Lantern, Marathon Health team up to launch integrated care management model
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- CMS tightens oversight of accreditation organizations, limits fee-based consulting
- MedPAC offers a look at enrollment hiccups for Medicare beneficiaries
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- US telehealth utilization climbs 10.1% in Q1, led by mental health visits: Fair Health
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Uncovr secures $7M in seed funding for AI surgical documentation platform
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
- Stealth BioTherapeutics removes cloak to become Mighty
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- DeepIntent gives Helix an AI twist to help marketers query data
- PhRMA talks up the power of ‘Medicines First’ in new campaign
- Centene offering staff buyouts as it navigates murky ACA waters
- KFF: Insurer participation in the ACA marketplaces declined from 2025 to 2026
- Organic Baby Formula Recalled Following Botulism Cases
- Germany backs off plan to install variable discount pricing on drugs: report
- Judge tosses multiple provisions of CMS' 2025 ACA program integrity rule
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- IQVIA taps AI to put overlooked prescribers on marketers’ maps
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod
- Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Fentanyl Users Take Daily Doses 60 Times The Lethal Level
- Final Rules For Medicaid Work Requirements Are Out. Here's What You Need To Know.
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Sepsis, Lung Infection Patients See No Benefit From Remote Monitoring
- Overlooked Social Connections Can Prevent Suicide
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- How lab data powers precision commercialization to drive therapy adoption
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
- Eli Lilly cuts 340B discounts for hospitals resisting its claims data submission policy
Michigan healthcare freedom community forum
This is how you get your Cabinet nominees confirmed, double quick time, without histrionics. The Democrats stalling RFK, Jr. just ran out of slack. From Gizmodo, a mouthpiece of the left:
https://gizmodo.com/trump-orders-cdc-fda-and-other-health-agencies-to-go-dark-2000553437
Trump Orders CDC, FDA, and Other Health Agencies to Go Dark
The communications pause could be an early sign of things to come under a renewed Trump White House.
By Ed Cara | January 22, 2025The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the U.S. Department of Health and Human Services. This week, the returning Trump administration told these agencies to stop talking to the public—for how long, no one knows.
The Washington Post first broke news of Trump’s sweeping directive late Tuesday evening. Staff at these agencies have been reportedly ordered to cease external communication for the time being. The move is the latest to unnerve outside experts about the direction of the country’s public health infrastructure under Trump.
The order was delivered by Stefanie Spear, a newly hired deputy chief of staff at HHS, according to the Post. Spear was the press secretary for Robert F. Kennedy Jr. during his 2024 presidential campaign, who has since been nominated by Trump to lead HHS. Affected staff told the Post that the directive lacked specific details, including the reasoning behind it, how long the pause is expected to last, and whether there are any exceptions allowed.
Gizmodo reached out to the HHS for comment but did not hear back by the time of publication.
It’s certainly possible that the White House is simply trying to make it easier for its new health officials to transition into their roles. And this isn’t an unprecedented action for the White House to take to accomplish that, according to Carmen Marsit, executive associate dean at Emory University’s Rollins School of Public Health.
“It is not uncommon for a new administration to ask for a pause on communications, website updates, etc, in order for new leadership to review the information, understand how information flows, and then work to continue communications,” Marsit told Gizmodo in an email. At the same time, he added, the scope of this directive is currently unknown, as is its potential impact on the public.
Emerging outbreaks, new discoveries, and noteworthy drug approvals are just some of the many things that agencies like the CDC and FDA regularly communicate to the general public and clinicians. Research led by or conducted with the help of government scientists is also routinely published in the CDC’s Morbidity and Mortality Weekly Report (MMWR), which has often served as an early look into important health trends and crises (the first reported cases of what came to be known as HIV/AIDS, for instance). According to the Post, CDC staff were planning to publish several reports in the MMWR this week, including three concerning H5N1—a highly pathogenic strain of avian influenza that has increasingly started to infect cattle, other mammals, and humans since last year.
Halting communication from federal health agencies like the CDC, NIH, and FDA during an administration transition is highly problematic, especially with active public health threats like the H5N1 outbreak in the U.S. and the Marburg outbreak in Tanzania, according to Krutika Kuppalli, an infectious disease physician in Dallas with experience in global health and pandemic preparedness.
“A blanket suspension of external communication from health agencies is unusual and potentially harmful,” Kuppalli told Gizmodo. “Trust in institutions like the CDC is built on transparency and reliability. A lack of communication could lead to skepticism or distrust, making it harder to re-establish credibility when communication resumes.”
There’s also past history to consider, as the Trump-led White House has a track record of muzzling its federal agencies and scientists. In the early days of Trump’s first term, the administration similarly ordered several agencies, including the United States Department of Agriculture, to temporarily stay quiet (much of this directive was quickly revised, however). More worryingly, the Trump administration prevented health officials from communicating with the press and public in the early months of the covid-19 pandemic, while his staff reportedly later tried to alter reports from the CDC concerning covid-19—allegedly with the goal of downplaying the harms of the pandemic.
The potential next leader of HHS, RFK Jr., has also made it clear that he wants to dramatically change the direction of the country’s public health agencies, and likely not for the better. RFK Jr. has regularly espoused false or misleading statements about vaccines and other health-related topics, for instance, and he’s promised to suspend government-led research on infectious diseases if given the chance. And earlier this week, Trump signed an executive order reinstating his plan to have the U.S. leave the World Health Organization, which has played a vital role in supporting public health globally.
“The CDC collaborates with international partners to tackle global health challenges,” noted Kuppalli, who has previously worked with the WHO as a medical officer on covid-19. “The planned withdrawal from WHO already has implications for the U.S.’ role in global health, but a communication freeze could further undermine the U.S.’ reputation as a leader in public health.”
Should this pause linger on, it may be an early indication that the CDC and other agencies will face new challenges from the Trump administration that might prevent them from communicating honestly with the public. And that’s likely to bode very badly for the rest of us.
“While it is the prerogative of any administration to align federal agencies with their vision and goals, public health must remain a nonpartisan priority,” Kuppalli said. “Ensuring continuity of communication from agencies like the CDC, FDA and NIH during transitional periods is not only wise but essential for safeguarding the health and well-being of the public.”
Federal health employee travel has been curtailed. Participation in and sponsorship of external meetings has also been suspended:
US health agencies cancel external meetings, travel after Trump admin directives
By Julie Steenhuysen - January 23, 2025Summary
* 'One Health' bird flu call canceled this week -source
* Travel ban enacted for all health agency employees
* CDC weekly publication of scientific reports did not publish on ThursdayCHICAGO, Jan 23 (Reuters) - U.S. health agencies including the CDC this week canceled meetings with external groups, paused some public health publications and told employees to freeze travel after directives from the Department of Health and Human Services, two sources familiar with the situation said.
On Wednesday, a state/federal call scheduled for Thursday involving states affected by H5N1 bird flu in dairy cattle and other animals was canceled, one of the sources said. It also postponed a training session for public health practitioners, the source said.
The source said the H5N1 bird flu calls occur on a regular schedule, and was aware only that the Thursday session, which was designated a "One Health" call involving both human and animal health issues, was canceled.
Presidential transitions often involve some pause in communications but the source characterized the current scope as broad.
South Dakota's state veterinarian Beth Thompson confirmed that the Centers for Disease Control and Prevention on Wednesday canceled an upcoming, regularly scheduled call with state veterinarians that would normally focus on bird flu. "There was no reason given," she said.
However, the U.S. Department of Agriculture did hold a regularly scheduled call on Wednesday on tracing the location of diseased or at-risk animals through its Veterinary Services program, Thompson said.
Scientists and public health officials are growing increasingly concerned about the spread of H5N1 bird flu, which has infected nearly 70 people in the U.S. since April. Most cases have been mild and occurred in farm workers, according to the CDC.
Earlier this month, however, the United States reported its first death from bird flu after an older person was exposed to a combination of backyard chickens and wild birds.
The cancellations followed a memo from acting HHS Secretary Dorothy Fink seen by Reuters that called for an immediate pause on issuing documents and public communications, including on any speaking engagements until the material has been reviewed and approved by a presidential appointee.
The pause is intended to extend through Feb. 1.
HHS said in a statement that its pause was for public communications not directly related to emergencies or critical to preserving health, and said exceptions for mission critical communications would be made on a case-by-case basis.
A travel ban directive was sent in a Jan. 21 memo to financial officers and travel officials within all operating divisions of HHS, including the National Institutes of Health, the Food and Drug Administration and the CDC, according to an HHS official who was not authorized to speak publicly on the matter.
The travel ban is in effect until further notice, according to the HHS official, who read portions of the memo to Reuters.
It specifies that any speaking engagements that had been accepted prior to Jan. 20 must be canceled.
Travel is only authorized for people who have already departed on an official trip, and the traveler must return to the original point of departure.
Employees from the Indian Health Service are exempted from the suspension.
While a few health communications have been issued since the ban – the FDA on Wednesday put out details of a new safety warning on a drug, for instance – others were canceled.
FIRST PAUSE SINCE 1960
The CDC's Morbidity and Mortality Weekly report, or MMWR, which includes scientific reports from the agency and outside scientists, was not published on Thursday as planned. HHS did not comment on when publication would resume.
In a post on X, former CDC director Dr. Tom Frieden said the MMWR, which is used to inform health officials about emerging threats, had been published weekly without pause since 1960. Delays in its publication put Americans' health at risk, Frieden said.
Dr. Jeremy Faust, a Boston-based emergency physician and author of the Inside Medicine newsletter published on the Substack platform, said the NIH was told to halt the process that approves funding for new scientific and medical research, citing an email shown to him by an NIH official.
The memo noted that all such advisory meetings had been canceled, but noted that such work would be rescheduled.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















